Reporting for the first time as a combined entity, Biogen Idec Inc. missed consensus earnings estimates by 8 cents, posting pro forma earnings per share of 24 cents for the fourth quarter. Its full-year adjusted EPS totaled $1.22. (BioWorld Today) Read More